Efficacy and Safety of Linagliptin/Metformin Fixed-Dose Combination (FDC) as Initial Therapy in Asian Patients with Type 2 Diabetes (T2D) and Severe Hyperglycemia

被引：0
|
作者：
Mu, Yiming
Pan, Changyu
Fan, Bei
Hehnke, Uwe
Gong, Yan
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1218-P
引用
收藏
页码：A315 / A315
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Linagliptin/Metformin Fixed-Dose Combination (FDC) as Initial Therapy in Drug-Naive Asian Patients with Type 2 Diabetes (T2D)
    Pan, Changyu
    Mu, Yiming
    Fan, Bei
    Hehnke, Uwe
    Gong, Yan
    DIABETES, 2015, 64 : A323 - A323
  • [2] Efficacy and safety of linagliptin/metformin fixed-dose combination as initial therapy in drug-naive Asian patients with type 2 diabetes
    Gong, Y.
    Mu, Y.
    Fan, B.
    Hehnke, U.
    Pan, C.
    DIABETOLOGIA, 2015, 58 : S388 - S388
  • [3] Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes
    Lingvay, Ildiko
    Beetz, Nadine
    Sennewald, Regina
    Schuler-Metz, Annette
    Bertulis, Julia
    Loley, Christina
    Lang, Benjamin
    Lippert, Caroline
    Lee, Jisoo
    Manning, Linda Shapiro
    Terada, Derek
    POSTGRADUATE MEDICINE, 2020, 132 (04) : 337 - 345
  • [4] Efficacy and safety of fixed-dose combination therapy, alogliptin plus metformin, in Asian patients with type 2 diabetes: A phase 3 trial
    Ji, Linong
    Li, Ling
    Kuang, Jian
    Yang, Tao
    Kim, Dong-Jun
    Kadir, Azidah A.
    Huang, Chien-Ning
    Lee, Douglas
    DIABETES OBESITY & METABOLISM, 2017, 19 (05): : 754 - 758
  • [5] Initial Combination with Linagliptin and Metformin in Newly Diagnosed Type 2 Diabetes and Severe Hyperglycemia
    Thomas Haak
    Advances in Therapy, 2012, 29 : 1005 - 1015
  • [6] Initial Combination with Linagliptin and Metformin in Newly Diagnosed Type 2 Diabetes and Severe Hyperglycemia
    Haak, Thomas
    ADVANCES IN THERAPY, 2012, 29 (12) : 1005 - 1015
  • [7] Linagliptin/Metformin Fixed-Dose Combination Treatment: A Dual Attack to Type 2 Diabetes Pathophysiology
    Chrysi Koliaki
    John Doupis
    Advances in Therapy, 2012, 29 : 993 - 1004
  • [8] Linagliptin/Metformin Fixed-Dose Combination Treatment: A Dual Attack to Type 2 Diabetes Pathophysiology
    Koliaki, Chrysi
    Doupis, John
    ADVANCES IN THERAPY, 2012, 29 (12) : 993 - 1004
  • [9] Linagliptin Monotherapy Versus Initial Combination Therapy with Metformin in Patients with Newly Diagnosed Type 2 Diabetes (T2D): A Randomized Controlled Trial
    von Eynatten, Maximilian
    Ross, Stuart
    Caballero, Enrique
    Del Prato, Stefano
    Gallwitz, Baptist
    Lewis-D'Agostino, Diane
    Bailes, Zelie
    Thiemannt, Sandra
    Patel, Sanjay
    Woerle, Hans-Juergen
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [10] Efficacy and safety of linagliptin/metformin single-pill combination as initial therapy in drug-naive Asian patients with type 2 diabetes
    Mu, Yiming
    Pan, Changyu
    Fan, Bei
    Hehnke, Uwe
    Zhang, Xiuzhen
    Zhang, Xuejun
    Wang, Xiaoyue
    Liu, Jingdong
    Zhang, Ying
    Du, Jianling
    Ma, Jianhua
    Gong, Yan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 124 : 48 - 56
12345